Mary Ann Liebert Inc. to Publish Dermatitis®

New Rochelle, NY, June 21, 2022 - The American Contact Dermatitis Society® (ACDS) is pleased to announce that it has selected Mary Ann Liebert, Inc. as the new publisher of Dermatitis®, starting in January 2023.

The Journal adds a dynamic component to Mary Ann Liebert, Inc.’s renowned portfolio of peer-reviewed journals in clinical medicine and biomedical research, including Facial Plastic Surgery & Aesthetic Medicine, Advances in Wound Care, and Photobiomodulation, Photomedicine, and Laser Surgery. Dermatitis® will continue to be published bimonthly in print and online formats, with open access options.

“We are tremendously honored to be the new publisher of Dermatitis® and to have the pleasure of working with the exceptional ACDS leadership team,” says Sophie Reisz, Vice President and Executive Editor at Mary Ann Liebert, Inc. “We are eager to continue to uphold the values, mission, and dedication of the Journal and Society as the field continues to develop and flourish.”

“During the process of reviewing publishers, we were struck by the personal manner in which the people at Mary Ann Liebert worked with us,” says Dr. Douglas Powell, President of the American Contact Dermatitis Society. “They were very attentive to every question and concern we posed to them and follow up with their existing society journals confirms this impression as well. We are very excited to work with Bob, Sophie, and the other good people at Mary Ann Liebert as our Journal continues to progress.”

Dermatitis® is a peer-reviewed journal and a critical resource for health care professionals in the field of allergic contact dermatitis and related inflammatory skin diseases. Dermatitis® focuses on contact, atopic, occupational, drug-induced dermatitis, and environmental dermatitis. Features unique to the Journal are Allergen of the Year and Contact Allergen Alternatives, Images in Dermatitis, Pearls & Zebras, Product Allergen Watch, and news, features, or meeting abstracts from participating organizations.

For further information about Dermatitis®, please visit:

About the American Contact Dermatitis Society®:

The American Contact Dermatitis Society® (ACDS) was founded in 1989 and has grown from a small, dedicated group of dermatologists focused on contact dermatitis to over 2,500 health care professionals in the field of allergic contact dermatitis and related inflammatory skin diseases. The mission of the Society is to be the premier organization cultivating advancements in the diagnosis and care of dermatitis through the promotion of education, research, and advocacy. The Society is dedicated to understanding, and investigating the interplay among, contact, occupational, atopic, drug, environmental and other forms of dermatitis.

For more information, or to schedule an interview with an ACDS spokesperson, please contact Ginger Czajkowski, Executive Director of the American Contact Dermatitis Society at

About the Publisher

Mary Ann Liebert, Inc. is a leading independent publisher known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology and regenerative medicine, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law and policy, environmental research and policy, and other specialized disciplines. The company publishes more than 100 peer-reviewed journals, leading trade magazines, and specialized newsletters which make critical contributions in advancing research and facilitating collaboration throughout the world in academia, industry, and government.

For more information, or to schedule an interview with a publisher spokesperson, please contact: Kathryn Ryan, Mary Ann Liebert, Inc., publishers, 914-740-2100 or



ACDS® | 555 East Wells Street, Suite 1100 | Milwaukee, WI 53202
Tel: (414) 918-9805 | Fax: (414) 276-3349 | Email:

Follow us


Support ACDS with AmazonSmile
ACDS: Amazon Smile

If you do not wish to be included in our mailing list, please forward this message to